Elanco Animal Health Inc
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
SEE REMARKS
Deferred Stock Units
Derivative security · not the ordinary share price.
PRESIDENT, CEO AND DIRECTOR
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP and CFO
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
PRESIDENT, CEO AND DIRECTOR
Deferred Stock Units
Derivative security · not the ordinary share price.
SEE REMARKS
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP and CFO
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP and CFO
Deferred Stock Units
Derivative security · not the ordinary share price.
SEE REMARKS
Deferred Stock Units
Derivative security · not the ordinary share price.
PRESIDENT, CEO AND DIRECTOR
Deferred Stock Units
Derivative security · not the ordinary share price.
SEE REMARKS
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP and CFO
Deferred Stock Units
Derivative security · not the ordinary share price.
PRESIDENT, CEO AND DIRECTOR
Deferred Stock Units
Derivative security · not the ordinary share price.
PRESIDENT, CEO AND DIRECTOR
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP and CFO
Deferred Stock Units
Derivative security · not the ordinary share price.
SEE REMARKS
Deferred Stock Units
Derivative security · not the ordinary share price.
PRESIDENT, CEO AND DIRECTOR
Deferred Stock Units
Derivative security · not the ordinary share price.
SEE REMARKS
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP and CFO
Deferred Stock Units
Derivative security · not the ordinary share price.
PRESIDENT, CEO AND DIRECTOR
Deferred Stock Units
Derivative security · not the ordinary share price.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| SEE REMARKS | Deferred Stock UnitsGrant or award | Derivative units67$22.14 / derivative unit | $1.48K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| PRESIDENT, CEO AND DIRECTOR | Deferred Stock UnitsGrant or award | Derivative units128$22.14 / derivative unit | $2.83K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| EVP and CFO | Deferred Stock UnitsGrant or award | Derivative units9$22.14 / derivative unit | $197.02 | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units642$22.39 / derivative unit | $14.38K | Sep 30Filed Oct 1 · 1d later | SEC filing |
| PRESIDENT, CEO AND DIRECTOR | Deferred Stock UnitsGrant or award | Derivative units126$22.42 / derivative unit | $2.83K | Sep 18Filed Sep 22 · 4d later | SEC filing |
| SEE REMARKS | Deferred Stock UnitsGrant or award | Derivative units66$22.42 / derivative unit | $1.48K | Sep 18Filed Sep 22 · 4d later | SEC filing |
| EVP and CFO | Deferred Stock UnitsGrant or award | Derivative units9$22.42 / derivative unit | $197.02 | Sep 18Filed Sep 22 · 4d later | SEC filing |
| EVP and CFO | Deferred Stock UnitsGrant or award | Derivative units8$24.50 / derivative unit | $197.02 | Sep 4Filed Sep 9 · 5d later | SEC filing |
| SEE REMARKS | Deferred Stock UnitsGrant or award | Derivative units60$24.50 / derivative unit | $1.48K | Sep 4Filed Sep 9 · 5d later | SEC filing |
| PRESIDENT, CEO AND DIRECTOR | Deferred Stock UnitsGrant or award | Derivative units115$24.50 / derivative unit | $2.83K | Sep 4Filed Sep 9 · 5d later | SEC filing |
| SEE REMARKS | Deferred Stock UnitsGrant or award | Derivative units62$23.97 / derivative unit | $1.48K | Aug 21Filed Aug 25 · 4d later | SEC filing |
| EVP and CFO | Deferred Stock UnitsGrant or award | Derivative units8$23.97 / derivative unit | $197.02 | Aug 21Filed Aug 25 · 4d later | SEC filing |
| PRESIDENT, CEO AND DIRECTOR | Deferred Stock UnitsGrant or award | Derivative units118$23.97 / derivative unit | $2.83K | Aug 21Filed Aug 25 · 4d later | SEC filing |
| PRESIDENT, CEO AND DIRECTOR | Deferred Stock UnitsGrant or award | Derivative units128$22.12 / derivative unit | $2.83K | Aug 7Filed Aug 10 · 3d later | SEC filing |
| EVP and CFO | Deferred Stock UnitsGrant or award | Derivative units9$22.12 / derivative unit | $197.02 | Aug 7Filed Aug 10 · 3d later | SEC filing |
| SEE REMARKS | Deferred Stock UnitsGrant or award | Derivative units67$22.12 / derivative unit | $1.48K | Aug 7Filed Aug 10 · 3d later | SEC filing |
| PRESIDENT, CEO AND DIRECTOR | Deferred Stock UnitsGrant or award | Derivative units113$24.91 / derivative unit | $2.83K | Jul 24Filed Jul 28 · 4d later | SEC filing |
| SEE REMARKS | Deferred Stock UnitsGrant or award | Derivative units59$24.91 / derivative unit | $1.48K | Jul 24Filed Jul 28 · 4d later | SEC filing |
| EVP and CFO | Deferred Stock UnitsGrant or award | Derivative units8$24.91 / derivative unit | $197.02 | Jul 24Filed Jul 28 · 4d later | SEC filing |
| PRESIDENT, CEO AND DIRECTOR | Deferred Stock UnitsGrant or award | Derivative units114$24.82 / derivative unit | $2.83K | Jul 10Filed Jul 14 · 4d later | SEC filing |
Showing the latest 20 of 67 trades. Show all 67 trades
Elanco Animal Health Incorporated Common Stock (ELAN) · Stock
The filing reports a sale for a spouse.
Valerie HoyleReporting House member$1,087,992 of common-equity purchase value after transaction-age decay across 180 days.
7 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
